Bacterial Infections: Cefuroxime is effective against a wide range of bacterial infections caused by susceptible organisms. These include:
Respiratory Tract Infections: Such as pneumonia, bronchitis, and sinusitis.
Ear Infections: Including acute otitis media.
Skin and Soft Tissue Infections: Such as cellulitis and impetigo.
Urinary Tract Infections (UTIs): Including cystitis and pyelonephritis.
Sexually Transmitted Infections (STIs): Such as gonorrhea.
Lyme Disease: Particularly for early localized or early disseminated stages.
Bone and Joint Infections: Such as osteomyelitis and septic arthritis.
Perioperative Prophylaxis: Cefuroxime is sometimes used to prevent surgical site infections.
Dosage and Administration: Cefuroxime is typically administered orally or intravenously. The dosage and duration of treatment depend on the type and severity of the infection, patient factors, and susceptibility patterns of the infecting organisms. It's usually administered multiple times per day.
Adverse Effects: Common side effects of cefuroxime may include diarrhea, nausea, vomiting, abdominal pain, rash, and allergic reactions such as itching or hives. It may also cause pseudomembranous colitis and anaphylaxis in rare cases. Additionally, it can lead to liver dysfunction and hematologic abnormalities.
Drug Interactions: Cefuroxime may interact with other medications, particularly those affecting renal function or interfering with the absorption of antibiotics. Care should be taken when administering cefuroxime concomitantly with other drugs to avoid potential interactions.
Impacted of cefuroxime sodium salt (antibiotic) On Probiotics
Rank
Probiotic
Impact
genus
Bifidobacterium
Reduces
species
Akkermansia muciniphila
Reduces
species
Bacteroides uniformis
Reduces
species
Bifidobacterium adolescentis
Reduces
species
Bifidobacterium animalis
Reduces
species
Bifidobacterium bifidum
Reduces
species
Bifidobacterium breve
Reduces
species
Bifidobacterium catenulatum
Reduces
species
Bifidobacterium longum
Reduces
species
Bifidobacterium pseudocatenulatum
Reduces
species
Bifidobacterium pseudolongum
Reduces
species
Escherichia coli
Reduces
species
Lacticaseibacillus paracasei
Reduces
species
Parabacteroides distasonis
Reduces
subspecies
Bifidobacterium longum subsp. infantis
Reduces
subspecies
Bifidobacterium longum subsp. longum
Reduces
Bacteria Impacted by cefuroxime sodium salt (antibiotic)
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
Impact of cefuroxime sodium salt (antibiotic) on Conditions from US National Library of Medicine
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups.
We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio: Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
This is an Academic site. It generates
theoretical models
of what may benefit a specific microbiome results.
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some
hallucinations.Please report any to us for correction.
Copyright 2016 - 2026 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription
All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [216.73.216 ]
